Global Probiotics Market- Industry Analysis, Share, Size, Growth, Trends, Opportunity and Forecast 2022-2030

1 INTRODUCTION
1.1 OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY DATA
1.2.2 PRIMARY DATA
1.2.3 MARKET SIZE ESTIMATION
1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.3 STAKEHOLDERS
1.4 RESEARCH ASSUMPTIONS
1.5 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 DEMAND SIDE ANALYSIS
3.7 SUPPLY SIDE ANALYSIS
3.8 PORTER’S FIVE FORCES MODEL
3.8.1 DEGREE OF COMPETITION
3.8.2 BARGAINING POWER OF BUYERS
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 THREAT FROM SUBSTITUTES
3.8.5 THREAT FROM NEW ENTRANTS
4 INDUSTRY TRENDS
4.1 PRODUCT LIFE CYCLE
4.2 NEW MARKET ENTRY STRATEGY
4.3 PESTEL ANALYSIS
4.4 PRICING ANALYSIS
4.5 TRADE DATA
4.6 TECHNOLOGICAL OVERVIEW
4.7 FUTURE OUTLOOK MARKET TRENDS
4.8 MACRO-ECONOMIC VARIABLES (DEPENDENT AND INDEPENDENT VARIABLES)
4.9 MULTIFACTOR BASED SENSITIVITY ANALYSIS
4.10 REGRESSION MATRIX
4.11 COVID-19 IMPACT ANALYSES
4.12 GE MATRIX
5 PROBIOTICSS TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2016-2020
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 PROBIOTIC FOOD & BEVERAGES
5.5.1 DAIRY
5.5.2 NON-DAIRY
5.5.3 CEREALS
5.5.4 BAKED FOOD
5.5.5 FERMENTED MEAT
5.5.6 DRY FOOD
5.6 PROBIOTIC DIETARY SUPPLEMENTS
5.6.1 FOOD SUPPLEMENTS
5.6.2 NUTRITIONAL SUPPLEMENTS
5.6.3 SPECIALTY NUTRIENTS
5.6.4 INFANT FORMULA
5.7 ANIMAL FEED PROBIOTICS
6 PROBIOTICSS INGREDIENT ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET INGREDIENT ANALYSIS, 2016-2020
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 BACTERIA
6.5.1 LACTOBACILLI
6.5.1.1 Lactobacillus acidophilus
6.5.1.2 Lactobacillus rhamnosus
6.5.1.3 Lactobacillus casei
6.5.1.4 Lactobacillus reuteri
6.5.2 BIFIDOBACTERIA
6.5.3 STREPTOCOCCUS THERMOPHILUS
6.6 YEAST
6.6.1 SACCHAROMYCES BOULARDII
6.6.2 OTHERS (SACCHAROMYCES CEREVISIAE AND SACCHAROMYCES BAYANUS)
7 PROBIOTICSS FUNCTION ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET FUNCTION ANALYSIS, 2016-2020
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 REGULAR
7.6 PREVENTATIVE HEALTHCARE
7.7 THERAPEUTIC
8 PROBIOTICSS FORM ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET FORM ANALYSIS, 2016-2020
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 DRY
8.6 LIQUID
9 PROBIOTICSS DISTRIBUTION CHANNEL ANALYSIS
9.1 INTRODUCTION
9.2 HISTORICAL MARKET DISTRIBUTION CHANNEL ANALYSIS, 2016-2020
9.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
9.4 Y-O-Y GROWTH TREND ANALYSIS
9.5 HYPERMARKETS/SUPERMARKETS
9.6 PHARMACIES/DRUG STORES
9.7 SPECIALTY STORES
9.8 ONLINE STORES
10 PROBIOTICSS MARKET APPLICATION ANALYSIS
10.1 INTRODUCTION
10.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020
10.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.4 Y-O-Y GROWTH TREND ANALYSIS
10.5 HUMAN
10.6 ANIMAL
11 GLOBAL PROBIOTICSS REGIONAL ANALYSIS
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
11.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
11.2.3 Y-O-Y GROWTH TREND ANALYSIS
11.2.3.1 U.S.
11.2.3.2 Canada
11.2.3.3 Mexico
11.3 ASIA-PACIFIC
11.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
11.3.2 Y-O-Y GROWTH TREND ANALYSIS
11.3.2.1 China
11.3.2.2 Japan
11.3.2.3 Korea
11.3.2.4 India
11.3.2.5 Southeast Asia
11.4 MIDDLE EAST AND AFRICA
11.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
11.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
11.4.3 Y-O-Y GROWTH TREND ANALYSIS
11.4.3.1 Saudi Arabia
11.4.3.2 UAE
11.4.3.3 Egypt
11.4.3.4 Nigeria
11.4.3.5 South Africa
11.5 EUROPE
11.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
11.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
11.5.3 Y-O-Y GROWTH TREND ANALYSIS
11.5.3.1 Germany
11.5.3.2 France
11.5.3.3 UK
11.5.3.4 Russia
11.5.3.5 Italy
11.6 SOUTH AMERICA
11.6.1 SOUTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
11.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
11.6.3 Y-O-Y GROWTH TREND ANALYSIS
11.6.3.1 Brazil
11.6.3.2 Argentina
11.6.3.3 Columbia
12 MARKET PLAYERS
12.1 ARLA FOODS, INC.
12.1.1 BUSINESS OVERVIEW:
12.1.2 PRODUCT PORTFOLIO
12.1.3 RECENT DEVELOPMENTS
12.1.4 SWOT ANALYSIS:
12.2 CHR. HANSEN HOLDING A/S
12.3 DANONE
12.4 DANISCO A/S
12.5 GENERAL MILLS, INC.
12.6 I-HEALTH, INC.
12.7 LALLEMAND, INC.
12.8 LIFEWAY FOODS, INC.
12.9 MOTHER DAIRY FRUIT & VEGETABLE PVT. LTD.
12.10 KERRY
12.11 NESTLE S.A.
12.12 PROBI
12.13 YAKULT HONSHA CO., LTD.
12.14 BIOGAIA AB
12.15 E. I. DU PONT DE NEMOURS AND COMPANY
12.16 GANEDEN, INC.
12.17 PROTEXIN
13 ABOUT US

FIGURE 1 GLOBAL PROBIOTICSS MARKET, 2021–2030, (USD MILLION)
FIGURE 2 RESEARCH METHODOLOGY
FIGURE 3 GLOBAL PROBIOTICSS CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 4 GLOBAL PROBIOTICSS CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 5 MARKET OVERVIEW
FIGURE 6 SWOT ANALYSIS
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 SUPPLY CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 PROBIOTICSS TYPE ANALYSIS
FIGURE 11 GLOBAL PROBIOTICSS CURRENT AND FUTURE MARKET TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 12 PROBIOTICSS INGREDIENT ANALYSIS
FIGURE 13 GLOBAL PROBIOTICSS CURRENT AND FUTURE MARKET INGREDIENT ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 14 PROBIOTICSS FUNCTION ANALYSIS
FIGURE 15 GLOBAL PROBIOTICSS CURRENT AND FUTURE MARKET FUNCTION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 16 PROBIOTICSS FORM ANALYSIS
FIGURE 17 GLOBAL PROBIOTICSS CURRENT AND FUTURE MARKET FORM ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 18 PROBIOTICSS DISTRIBUTION CHANNEL ANALYSIS
FIGURE 19 GLOBAL PROBIOTICSS CURRENT AND FUTURE MARKET DISTRIBUTION CHANNEL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 20 PROBIOTICSS APPLICATION ANALYSIS
FIGURE 21 GLOBAL PROBIOTICSS CURRENT AND FUTURE MARKET APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 22 GLOBAL PROBIOTICSS CURRENT AND FUTURE MARKET VOLUME SHARE REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 23 MARKET OVERVIEW, REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 24 MARKET SHARE BY COUNTRY
FIGURE 25 NORTH AMERICA PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 26 NORTH AMERICA PROBIOTICSS CURRENT AND FUTURE INGREDIENT ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 27 NORTH AMERICA PROBIOTICSS CURRENT AND FUTURE FUNCTION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 28 NORTH AMERICA PROBIOTICSS CURRENT AND FUTURE FORM ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 29 NORTH AMERICA PROBIOTICSS CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 30 NORTH AMERICA PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 31 U.S. PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 32 U.S. PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 33 CANADA PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 34 CANADA PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 35 MEXICO PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 36 MEXICO PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 37 MARKET SHARE BY COUNTRY
FIGURE 38 APAC PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 39 APAC PROBIOTICSS CURRENT AND FUTURE INGREDIENT ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 40 APAC PROBIOTICSS CURRENT AND FUTURE FUNCTION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 41 APAC PROBIOTICSS CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 42 APAC PROBIOTICSS CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 43 APAC PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 44 CHINA PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 45 CHINA PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 46 JAPAN PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 47 JAPAN PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 48 KOREA PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 49 KOREA PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 50 INDIA PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 51 INDIA PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 52 SOUTHEAST ASIA PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 53 SOUTHEAST ASIA PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 54 MARKET SHARE BY COUNTRY
FIGURE 55 MIDDLE EAST AND AFRICA PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 56 MIDDLE EAST AND AFRICA PROBIOTICSS CURRENT AND FUTURE INGREDIENT ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 57 MIDDLE EAST AND AFRICA PROBIOTICSS CURRENT AND FUTURE FORM ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 58 MIDDLE EAST AND AFRICA PROBIOTICSS CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 59 MIDDLE EAST AND AFRICA PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 60 SAUDI ARABIA PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 61 SAUDI ARABIA PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 62 UAE PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 63 UAE PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 64 EGYPT PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 65 EGYPT PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 66 NIGERIA PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 67 NIGERIA PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 68 SOUTH AFRICA PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 69 SOUTH AFRICA PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 70 MARKET SHARE BY COUNTRY
FIGURE 71 EUROPE PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 72 EUROPE PROBIOTICSS CURRENT AND FUTURE INGREDIENT ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 73 EUROPE PROBIOTICSS CURRENT AND FUTURE FUNCTION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 74 EUROPE PROBIOTICSS CURRENT AND FUTURE FORM ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 75 EUROPE PROBIOTICSS CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 76 EUROPE PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 77 GERMANY PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 78 GERMANY PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 79 FRANCE PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 80 FRANCE PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 81 UK PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 82 UK PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 83 RUSSIA PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 84 RUSSIA PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 85 ITALY PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 86 ITALY PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 87 MARKET SHARE BY COUNTRY
FIGURE 88 SOUTH AMERICA PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 89 SOUTH AMERICA PROBIOTICSS CURRENT AND FUTURE INGREDIENT ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 90 SOUTH AMERICA PROBIOTICSS CURRENT AND FUTURE FORM ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 91 SOUTH AMERICA PROBIOTICSS CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 92 SOUTH AMERICA PROBIOTICSS CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 93 SOUTH AMERICA PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 94 BRAZIL PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 95 BRAZIL PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 96 ARGENTINA PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 97 ARGENTINA PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 98 COLUMBIA PROBIOTICSS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 99 COLUMBIA PROBIOTICSS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 100 FINANCIAL OVERVIEW: